Boots owner plans £5bn sale of chemist chain

Until recently Boots has faced criticism for refusing to invest in its shops. But under Sebastian James, the former Dixons Carphone boss, stores have been modernised in a move that some speculated was priming the business for a sale.

In addition, sluggish trading has turned a corner. It has long been a laggard among Walgreens’ businesses and has suffered as shoppers shun town and city centres.

Nevertheless, one investment banker said there was likely to be significant interest if an auction goes ahead. “If you don’t go to Boots, where else is there?” they said, in reference to the fact that the company has an almost unrivalled retail network in the UK. 

A potential auction will stoke speculation that another of Britain’s best-known retailers is set to fall into the hands of a private equity buyer.

Morrisons recently agreed a £10bn sale to US buyout firm Clayton Dublier & Rice. And last year Asda was bought by the petrol forecourt tycoons the Issa brothers in conjunction with UK private equity house TDR Capital.

A sale of Boots is likely to face government scrutiny. The retailer plays a crucial role in the delivery of pharmacy services and could yet have a greater role to play in combating coronavirus in years to come.

A Walgreens Boots Alliance spokesman said the company did not comment on market speculation and that Boots was an important part of the group. 

He added: “However, it is accurate that WBA announced a renewed set of priorities and strategic direction in October, which includes a more pointed focus on North America and on healthcare.

“As underlined during the last WBA investor conference, the group continues to be very pleased with the performance of Boots and the international division as a whole.”